COVID-19 and related symptoms in patients under disulfiram for alcohol use disorder.

Tamburin, Stefano; Mantovani, Elisa; De Bernardis, Ernesto; Zipeto, Donato; Lugoboni, Fabio

Tamburin, Stefano; Mantovani, Elisa; De Bernardis, Ernesto; Zipeto, Donato; Lugoboni, Fabio.

Tamburin S; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Piazzale Scuro 10, 37134, Verona, Italy. stefano.tamburin@univr.it.
Mantovani E; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Piazzale Scuro 10, 37134, Verona, Italy.
De Bernardis E; Addiction Medicine Unit, Siracusa Province Health Agency, Lentini, Italy.
Zipeto D; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Piazzale Scuro 10, 37134, Verona, Italy.
Lugoboni F; Department of Medicine, Addiction Medicine Unit, Verona University Hospital, Verona, Italy.

Intern Emerg Med ; 16(6): 1729-1731, 2021 09.

Article in English | MEDLINE | ID: covidwho-1037266

Subject(s)

Alcoholism; COVID-19; Alcoholism/complications; Disulfiram/therapeutic use; Humans; SARS-CoV-2

Keywords

Alcohol related liver disease; Alcohol use disorder; COVID-19; Disulfiram; SARS-CoV-2; Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Alcoholism / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: Intern Emerg Med Journal subject: Emergency Medicine / Internal Medicine Year: 2021 Document Type: Article Affiliation country: S11739-021-02633-y

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google